Drug
Rbd4059
Rbd4059: highest development phase Phase 1, developed by Suzhou Ribo Life Science Co. Ltd.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Suzhou Ribo Life Science Co. Ltd.
Trials
| Drug | Phase | Indication |
|---|---|---|
| RBD4059 NCT07930767 | Phase 1 |
Latest
No recent events.
Follow Rbd4059 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.